Canada· CA-DIN-02541742
MYFEMBREE
A relugolix, estradiol und norethisteron product containing relugolix + estradiol + norethindrone acetate, registered in Canada by SUMITOMO PHARMA SWITZERLAND GMBH. The same ATC class is registered in 11 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Relugolix, estradiol und norethisteron is registered in 11 of 19 countries.
Countries holding a registration under ATC H01CC54 (relugolix, estradiol und norethisteron), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 7 of them publish a price we can compare per daily dose
Relugolix, estradiol und norethisteron · ATC H01CC54
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- RELUGOLIX + ESTRADIOL + NORETHINDRONE ACETATE
- Manufacturer
- SUMITOMO PHARMA SWITZERLAND GMBH
- Country
- Canada (CA)
- ATC code
- H01CC54
- ATC class
- Relugolix, Estradiol und Norethisteron
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Relugolix, estradiol und norethisteron in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandRyeqo, FilmtablettenGedeon Richter (Schweiz) AG
- NorwayRyeqoOrifarm AS
- United KingdomRyeqo 40mg/1mg/0.5mg tabletsGedeon Richter (UK) Ltd
- PolandRyeqoGedeon Richter Plc.
- SwedenRyeqo 40 mg/1 mg/0,5 mg Filmdragerad tablettGedeon Richter Plc
- NetherlandsRyeqo 40 mg/1 mg/0.5 mg, filmomhulde tablettenGedeon Richter Plc
- SpainRYEQO 40 MG/1 MG/0,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULAGedeon Richter Plc.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Ryeqo
- Liechtenstein · Ryeqo
- Norway · Ryeqo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cbef09f0-3888-4877-88f0-b66fa758bf88 GET /v1/drugs/cbef09f0-3888-4877-88f0-b66fa758bf88?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02541742",
"form": "TABLET",
"class": "Human",
"routes": [
"ORAL"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "H01CC54",
"schedule": [
"Prescription"
],
"drug_code": "103029",
"strengths": [
"40 MG",
"1 MG",
"0.5 MG"
],
"ahfs_class": null,
"substances": [
"RELUGOLIX",
"ESTRADIOL",
"NORETHINDRONE ACETATE"
],
"product_categorization": null
}See everything about relugolix, estradiol und norethisteron.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.